Teva Pharmaceutical Industries, Ltd.: all 671 studies
Page 1 of 7. Open to participants first (7), then studies with results posted, then the rest; newest registration first within each.
- Two Trials to Evaluate TEV-53408 in Participants With Non-Segmental VitiligoNot yet recruitingNCT07920211Phase 2/3
- Real-World Impact of TV-44749 in Adults With SchizophreniaNot yet recruitingNCT07913100
- A Trial to Assess TEV-56286 at Different Doses in Healthy ParticipantsRecruitingNCT07674940Phase 1
- An Extension Trial to Test if TEV-56286 is Effective in Relieving Multiple System AtrophyRecruitingNCT07197866Phase 2
- A Trial to Test the Safety and Efficacy of TEV-53408 in Participants With VitiligoRecruitingNCT06625177Phase 1
- An Open-label Dose Escalation/Expansion Trial to Evaluate the Safety and Anti-tumor Activity of TEV-56278 Alone or in Combination With Pembrolizumab in Participants With Advanced or Metastatic Solid TumorsRecruitingNCT06480552Phase 1
- Fremanezumab Managed Access Program for Pediatric PatientsAvailableNCT03539393
- Real World Effectiveness and Safety of Deutetrabenazine in Adult Chinese Participants With Huntington's Disease (HD) Chorea in ChinaCompletedNCT07601516Phase 4Results posted
- Open-label Trial Characterizing the PK of 3 SC Olanzapine Extended-release Formulations in Participants With Schizophrenia/Schizoaffective DisorderCompletedNCT06319170Phase 1Results posted
- Safety, Tolerability, and Pharmacokinetic Study of TV-44749 in Chinese Patients With SchizophreniaCompletedNCT06253546Phase 1Results posted
- A Randomized, Double-Blind, Placebo-Controlled Study With an Open-Label, Long-Term Safety Phase to Evaluate the Efficacy and Safety of TV-44749 in Adults With SchizophreniaCompletedNCT05693935Phase 3Results posted
- Study Comparing Estradiol Vaginal Inserts 4mcg To IMVEXXY ® (Estradiol Vaginal Inerts 4 mcg) In The Treatment Of Dyspareunia in Women With Vulvur and Vaginal AtrophyCompletedNCT05617820Phase 3Results posted
- A Study of Modakafusp Alfa Together With Daratumumab Adults With Relapsed or Refractory Multiple MyelomaTerminatedNCT05590377Phase 1/2Results posted
- A Study of Modakafusp Alfa in Adult Participants With Multiple MyelomaTerminatedNCT05556616Phase 1Results posted
- Study Comparing Trifarotene Cream, 0.005% To AKLIEF ® (Trifarotene 0.005% Cream) In The Treatment Of Acne VulgarisCompletedNCT05550337Phase 3Results posted
- A Study to Test the Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's DiseaseCompletedNCT05499130Phase 2Results posted
- A Randomized, Double-Blind, Placebo-Controlled Study With an Open-Label Period on Efficacy and Safety of Fremanezumab in Chinese Adults With MigraineCompletedNCT05458011Phase 3Results posted
- Study to Compare Efficacy and Safety of TEV-45779 With XOLAIR (Omalizumab) in Adults With Chronic Idiopathic UrticariaCompletedNCT04976192Phase 3Results posted
- A Study to Test if TEV-53275 is Effective in Relieving AsthmaTerminatedNCT04847674Phase 2Results posted
- A Study to Test if TVB-009P is Effective in Relieving Postmenopausal OsteoporosisCompletedNCT04729621Phase 3Results posted
- A Study to Evaluate the Pharmacokinetics (PK) of Medroxyprogesterone Acetate Following an Injection of TV-46046 in Healthy Women of Reproductive AgeCompletedNCT04682353Phase 1Results posted
- A 24-Week Treatment Study to Compare Standard of Care Versus the eMDPI DS in Participants 13 Years or Older With AsthmaCompletedNCT04677959Phase 4Results posted
- A Study to Test if TEV-48574 is Effective in Relieving AsthmaTerminatedNCT04545385Phase 2Results posted
- A Trial to Test if Fremanezumab is Effective in Preventing Migraine in Children and AdolescentsCompletedNCT04530110Phase 3Results posted
- A Study to Test if Fremanezumab is Effective in Preventing Chronic Migraine in Participants 6 to 17 Years of AgeCompletedNCT04464707Phase 3Results posted
- A Study to Test if Fremanezumab is Effective in Preventing Episodic Migraine in Patients 6 to 17 Years of AgeCompletedNCT04458857Phase 3Results posted
- A Study to Test if TEV-50717 is Safe and Effective in Relieving Abnormal Involuntary Movements in Cerebral PalsyTerminatedNCT04200352Phase 3Results posted
- A Study of Modakafusp Alfa (TAK-573) Given by Itself and Together With Pembrolizumab in Adults With Advanced or Metastatic Solid TumorsTerminatedNCT04157517Phase 1/2Results posted
- A Study to Evaluate the Efficacy and Safety of Fremanezumab for Preventive Treatment of Migraine in Patients With Major Depressive DisorderCompletedNCT04041284Phase 4Results posted
- A Study to Test the Effectiveness and Safety of Fremanezumab on Participants With FibromyalgiaTerminatedNCT03965091Phase 2Results posted
- A Clinical Endpoint Bioequivalence Study of "Oxymetazoline Hydrochloride Cream"CompletedNCT03954444Phase 3Results posted
- A Study to Test if TV-46000 is Safe for Maintenance Treatment of SchizophreniaCompletedNCT03893825Phase 3Results posted
- A 12-Week Treatment Study to Evaluate the Effectiveness of Albuterol Multidose Dry Powder Inhaler With Integrated Electronic Module Digital System (eMDPI DS) in Participants13 Years or Older With AsthmaCompletedNCT03890666Phase 4Results posted
- A Study of TEV-50717 (Deutetrabenazine) for the Treatment of Dyskinesia in Cerebral Palsy in Children and AdolescentsCompletedNCT03813238Phase 3Results posted
- Therapeutic Equivalence of Two Formulations of Fluticasone Propionate and Salmeterol Inhalation Powder in Subjects With AsthmaCompletedNCT03756883Phase 3Results posted
- A Study to Evaluate Injection Pain and Local Tolerability Following Subcutaneous (SC) Administration of TV-46046CompletedNCT03700658Phase 1Results posted
- A Study to Test if TEV-50717 is Effective in Relieving Tics Associated With Tourette Syndrome (TS)CompletedNCT03571256Phase 3Results posted
- Evaluation of Safety and Tolerability of Long-term TEV-50717 (Deutetrabenazine) for Treatment of Tourette Syndrome in Children and AdolescentsTerminatedNCT03567291Phase 3Results posted
- Study to Evaluate TV-46000 as Maintenance Treatment in Adult and Adolescent Participants With SchizophreniaCompletedNCT03503318Phase 3Results posted
- Clinical Endpoint Study of Nepafenac 0.3% Opthalmic SuspensionCompletedNCT03499873Phase 3Results posted
- Alternatives for Reducing Tics in Tourette Syndrome (TS): A Study of TEV-50717 (Deutetrabenazine) for the Treatment of Tourette Syndrome in Children and AdolescentsCompletedNCT03452943Phase 2/3Results posted
- A Study to Test if Fremanezumab Reduces Headache in Participants With Posttraumatic Headache (PTH)CompletedNCT03347188Phase 2Results posted
- An Efficacy and Safety Study of Fremanezumab in Adults With MigraineCompletedNCT03308968Phase 3Results posted
- Clinical Endpoint Study of Ivermectin 0.5% LotionCompletedNCT03301649Phase 3Results posted
- Study to Evaluate Equivalence of Estradiol Vaginal Cream 0.01% to Estrace® Cream 0.01% in Atrophic VaginitisCompletedNCT03294538Phase 3Results posted
- A Study to Evaluate Safety and Equivalence of Generic Azelaic Acid Foam and Finacea® Foam in Participants With RosaceaCompletedNCT03287791Phase 3Results posted
- Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT03256695Phase 3Results posted
- A Study of Modakafusp Alfa on Adult Participants With Relapsed/Refractory Multiple MyelomaTerminatedNCT03215030Phase 1/2Results posted
- An Equivalence Study of Generic Ingenol Mebutate Gel 0.015% and Picato Gel 0.015% in Subjects With Actinic KeratosisCompletedNCT03200912Phase 3Results posted
- A Study to Explore the Long-Term Safety and Efficacy of Fremanezumab (TEV-48125) for the Prevention of Cluster HeadacheTerminatedNCT03107052Phase 3Results posted
- A Study of Reslizumab in Patients 12 Years of Age and Older With Severe Eosinophilic AsthmaTerminatedNCT03052725Phase 3Results posted
- Study of the Effect of a 5-Day Regimen of Study Drug on Peripheral Stem Cell Mobilization in Healthy ParticipantsTerminatedNCT03029000Phase 3Results posted
- Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate/Salmeterol Multidose Dry Powder InhalerCompletedNCT02980133Phase 3Results posted
- A Study to Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With AsthmaCompletedNCT02969408Phase 3Results posted
- A Study Comparing the Efficacy and Safety of Fremanezumab (TEV-48125) for the Prevention of Chronic Cluster Headache (CCH)TerminatedNCT02964338Phase 3Results posted
- A Study to Evaluate the Efficacy and Safety of TEV-48125 (Fremanezumab) for the Prevention of Episodic Cluster Headache (ECH)TerminatedNCT02945046Phase 3Results posted
- An Imaging Study Using PET/CT to Characterize the Effect of Intravenous Reslizumab on Airway InflammationTerminatedNCT02937168Phase 4Results posted
- Clinical Endpoint Study of Ivermectin 1% CreamCompletedNCT02840461Phase 3Results posted
- Study to Evaluate Suppression of Ovulation and Pharmacokinetics of Medroxyprogesterone Acetate Following Administration of TV-46046 in Women With Ovulatory CycleCompletedNCT02817464Phase 1Results posted
- Study of Equivalence of Generic Pimecrolimus Cream 1% and Elidel® 1% in Subjects With Mild to Moderate Atopic DermatitisCompletedNCT02791308Phase 3Results posted
- A Study of Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato Gel 0.05% in Subjects With Actinic KeratosisCompletedNCT02654769Phase 3Results posted
- Clinical End Point Study of Generic Adapalene and Benzoyl Peroxide Gel Versus Epiduo® Forte Gel in Treatment of Acne VulgarisCompletedNCT02651220Phase 3Results posted
- Efficacy and Safety of Subcutaneous Administration of Fremanezumab (TEV-48125) for the Preventive Treatment of MigraineCompletedNCT02638103Phase 3Results posted
- Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic MigraineCompletedNCT02629861Phase 3Results posted
- Comparing Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of TEV-48125 Versus Placebo for the Preventive Treatment of Chronic MigraineCompletedNCT02621931Phase 3Results posted
- Double-blind Placebo-controlled Trial of Generic Clindamycin/Benzoyl Peroxide Gel Versus Onexton Gel in Acne VulgarisCompletedNCT02616614Phase 3Results posted
- Multicenter, Double-blind, Placebo Controlled Comparing Test Fluorouracil Cream to Carac Cream in Actinic KeratosisCompletedNCT02616601Phase 3Results posted
- Study to Assess the Efficacy and Safety of Beclomethasone Dipropionate in Adolescent and Adult Patients 12 Years of Age and Older With Persistent AsthmaCompletedNCT02513160Phase 3Results posted
- Bioequivalence Study With Clinical Endpoint Comparing Brinzolamide 1% Ophthalmic Suspension to Azopt® 1% Ophthalmic Suspension In the Treatment of Chronic Open Angle Glaucoma or Ocular Hypertension in Both EyesCompletedNCT02512042Phase 3Results posted
- An Efficacy and Safety Study of Reslizumab Subcutaneous in Patients With Oral Corticosteroid Dependent Asthma and Elevated Blood EosinophilsCompletedNCT02501629Phase 3Results posted
- Study to Assess Medication Satisfaction in Patients With Relapsing Remitting Multiple Sclerosis Treated With Copaxone®CompletedNCT02499900Phase 4Results posted
- Study Comparing Rifaximin With Xifaxan 200 mg in Traveler's DiarrheaCompletedNCT02498418Phase 3Results posted
- A Study of Hyaluronate Injectable Viscosupplement for Treatment of Osteoarthritis of the KneeCompletedNCT02495857Not applicableResults posted
- Randomized, Placebo-Controlled, Multidose, Study Comparing Generic Budesonide/Formoterol Fumarate Dihydrate to Symbicort® in Asthmatic ParticipantsCompletedNCT02495168Phase 3Results posted
- Study to Evaluate the Analgesic Efficacy and Safety of Hydrocodone Bitartrate/Acetaminophen Immediate-Release Tablets in Participants With Moderate to Severe Pain Following BunionectomyCompletedNCT02487108Phase 3Results posted
- Study of Reslizumab in Participants With Uncontrolled Asthma and Elevated Blood EosinophilsCompletedNCT02452190Phase 3Results posted
- Study of TV-1106 in Growth Hormone-Deficient AdultsTerminatedNCT02410343Phase 3Results posted
- A Study to Evaluate the Safety and Efficacy of Topically Applied TV 45070 Ointment in Patients With Postherpetic Neuralgia (PHN)CompletedNCT02365636Phase 2Results posted
- Safety and Efficacy of Generic Diclofenac Epolamine Acute Pain Due to Minor Ankle SprainCompletedNCT02324270Phase 3Results posted
- Addressing Involuntary Movements in Tardive DyskinesiaCompletedNCT02291861Phase 3Results posted
- Randomized, Double-blind, Multiple-site, Placebo-controlled, Parallel-design Study in Patients With Moderate to Severe Facial Erythema Associated With RosaceaCompletedNCT02289352Phase 3Results posted
- A Phase 2 Clinical Study in Subjects With Primary Progressive Multiple Sclerosis to Assess the Efficacy, Safety and Tolerability of Two Oral Doses of Laquinimod Either of 0.6 mg/Day or 1.5mg/Day (Experimental Drug) as Compared to PlaceboCompletedNCT02284568Phase 2Results posted
- A Study To Evaluate The Safety And Therapeutic Equivalence of Tazarotene Foam 0.1% in Subjects With Acne VulgarisCompletedNCT02267746Phase 3Results posted
- Clinical Equivalence Study of Fluticasone Propionate Nasal Spray, 50 mcg/Actuation vs. Flonase in Allergic Rhinitis PatientsTerminatedNCT02246920Phase 3Results posted
- A Clinical Study in Participants With Huntington's Disease (HD) to Assess Efficacy and Safety of Three Oral Doses of LaquinimodCompletedNCT02215616Phase 2Results posted
- A Multi-center, Double-blind, Randomized Study, Comparing Clindamycin Phosphate Vaginal Cream 2% (Watson Laboratories, Inc.) to Clindesse® (Ther-Rx™, Clindamyin Phosphate Vaginal Cream 2%) and Both Active Treatments to a Placebo Control in the Treatment of Bacterial Vaginosis in Non-pregnant WomenCompletedNCT02210689Phase 3Results posted
- Reducing Involuntary Movements in Participants With Tardive DyskinesiaCompletedNCT02198794Phase 3Results posted
- Aim to Reduce Movements in Tardive DyskinesiaCompletedNCT02195700Phase 2/3Results posted
- A Study to Evaluate 5 μg/kg Tbo-filgrastim in Infants, Children and Adolescents With Solid Tumors Without Bone Marrow InvolvementCompletedNCT02190721Phase 2Results posted
- Long-Term Safety Study of Fluticasone Propionate (Fp) Multidose Dry Powder Inhaler (MDPI) and Fluticasone Propionate/Salmeterol (FS) MDPI in Patients With Persistent AsthmaCompletedNCT02175771Phase 3Results posted
- Efficacy and Safety Study of FP MDPI Compared With FS MDPI in Adolescent and Adult Patients With Persistent AsthmaCompletedNCT02141854Phase 3Results posted
- Study of Fluticasone Propionate MDPI Compared With Fluticasone/Salmeterol MDPI in Adolescent and Adult Patients With Persistent AsthmaCompletedNCT02139644Phase 3Results posted
- A Chronic-Dose Safety and Efficacy Study of Albuterol Multi-Dose Dry Powder Inhaler in Pediatric AsthmaticsCompletedNCT02126839Phase 3Results posted
- A Study to Evaluate the Safety and Clinical Study of Azelaic Acid Gel 15% in Patients With Moderate Facial RosaceaCompletedNCT02120924Phase 3Results posted
- A Study to Evaluate the Safety and Efficacy Imiquimod Cream, 2.5% in Participants With Actinic KeratosesCompletedNCT02120898Phase 3Results posted
- A Study to Evaluate the Pharmacokinetics, Safety,and Efficacy of Omacetaxine Given Subcutaneously as a Fixed Dose in Patients With Chronic Phase (CP) or Accelerated Phase (AP) Chronic Myeloid Leukemia (CML) (Referred to as the SYNSINCT Study)TerminatedNCT02078960Phase 1/2Results posted
- A Study to Evaluate the Safety and Efficacy of Topically Applied TV-45070 (Ointment) in Participants With Primary Osteoarthritis (OA) Affecting a Single KneeCompletedNCT02068599Phase 2Results posted
- Study to Evaluate the Mastery of Inhaler Technique for Budesonide Formoterol (BF) SPIROMAX® as Compared to SYMBICORT® TURBOHALER® as Treatment for Adult Participants With AsthmaCompletedNCT02062463Phase 3Results posted
- A 12-week Safety and Efficacy Study of Beclomethasone Dipropionate (80 and 160 mcg/Day) Delivered Via Breath-Actuated Inhaler (BAI) in Patients >=12 Years Old With Persistent AsthmaCompletedNCT02040779Phase 3Results posted
- A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants Ages 4-11 Years Old With Persistent AsthmaCompletedNCT02040766Phase 3Results posted
← Teva Pharmaceutical Industries, Ltd. overview and focus areas